What About the Audience?

Information may be provided to a broader range of consumers. No longer will results of studies be limited to regulators and scientific/medical cognoscenti. With greater access to posted documents on a variety of portals, the public will seek and access information that is important for informed decision-making. The patient will have a stronger voice in determining their treatment, and this will extend to end-of-life decisions. Social media will amplify results and will spread misinterpretations and poor-quality data. Caveat emptor!
Contributors include:
Samuel Entwisle, PhD, Medical Writer, Center for Information and Study on Clinical Research Participation (CISCRP), Boston, MA
Zack Fey, BS, Medical Writer, Center for Information and Study on Clinical Research Participation (CISCRP), Boston, MA